If you search the market caps of those listed companies you will see that many of the stage 1 companies - even those in pre clinical trials have market caps around and well above 100m.
It is all about the market size and probability of success. With washer and Mcdonald there coupled with the success of the WARF I am in.
Cannot deny peer analysis.